Maxim Group initiated coverage on Oncolytics Biotech with a new price target
$ONCY
Biotechnology: Pharmaceutical Preparations
Health Care
Maxim Group initiated coverage of Oncolytics Biotech with a rating of Buy and set a new price target of $3.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/6/2022 | $3.00 | Buy | Maxim Group |